000 01397 a2200433 4500
005 20250511151034.0
264 0 _c19790324
008 197903s 0 0 eng d
022 _a0009-9236
024 7 _a10.1002/cpt1979252137
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZiegler, M G
245 0 0 _aBromocriptine inhibits norepinephrine release.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cFeb 1979
300 _a137-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnimals
650 0 4 _aArteries
_xdrug effects
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aBromocriptine
_xpharmacology
650 0 4 _aElectric Stimulation
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMiddle Aged
650 0 4 _aNorepinephrine
_xmetabolism
650 0 4 _aPosture
650 0 4 _aRabbits
650 0 4 _aSympathetic Nervous System
_xdrug effects
650 0 4 _aVasoconstriction
_xdrug effects
700 1 _aLake, C R
700 1 _aWilliams, A C
700 1 _aTeychenne, P F
700 1 _aShoulson, I
700 1 _aSteinsland, O
773 0 _tClinical pharmacology and therapeutics
_gvol. 25
_gno. 2
_gp. 137-42
856 4 0 _uhttps://doi.org/10.1002/cpt1979252137
_zAvailable from publisher's website
999 _c779401
_d779401